relative to affordability and safety of clinician administered drugs.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text History 17 Sponsors 1

No text version has been ingested for this bill yet.

PASSAGE PROBABILITY

5.4% Unlikely

Why this number

Stage base In Committee — base rate 27%, measured from NH's completed sessions
Momentum -4 34/100 from the pace of recorded action
Time since last action -22 709 days quiet
Sponsor influence +4 92/100

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.